Sodium in PDB 7t84: Structure of Angiotensin II Type I Receptor (AT1R) Nanobody Antagonist AT118I4H32 G26D T57I Variant

The structure of Structure of Angiotensin II Type I Receptor (AT1R) Nanobody Antagonist AT118I4H32 G26D T57I Variant, PDB code: 7t84 was solved by G.R.Nemeth, M.A.Skiba, A.C.Kruse, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	46.32 / 1.60
Space group	P 1 21 1
Cell size a, b, c (Å), α, β, γ (°)	78.664, 89.19, 83.105, 90, 110.05, 90
R / Rfree (%)	16.5 / 19

The binding sites of Sodium atom in the Structure of Angiotensin II Type I Receptor (AT1R) Nanobody Antagonist AT118I4H32 G26D T57I Variant (pdb code 7t84). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Structure of Angiotensin II Type I Receptor (AT1R) Nanobody Antagonist AT118I4H32 G26D T57I Variant, PDB code: 7t84:

Sodium binding site 1 out of 1 in the Structure of Angiotensin II Type I Receptor (AT1R) Nanobody Antagonist AT118I4H32 G26D T57I Variant


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Structure of Angiotensin II Type I Receptor (AT1R) Nanobody Antagonist AT118I4H32 G26D T57I Variant within 5.0Å range: probe atom residue distance (Å) B Occ B:Na203 b:32.7 occ:1.00 OE1 A:GLN110 2.7 28.4 1.0 O B:LEU4 2.9 23.5 1.0 O A:HOH321 2.9 24.3 1.0 N B:GLN110 3.0 22.3 1.0 CA B:GLY109 3.5 22.3 1.0 CD A:GLN110 3.6 26.6 1.0 CG B:GLN110 3.6 28.3 1.0 CB B:GLN110 3.6 32.5 1.0 C B:GLY109 3.7 23.6 1.0 CG A:GLN110 3.7 25.4 1.0 CB A:GLN110 3.8 24.9 1.0 CA B:GLN110 3.8 25.7 1.0 C B:LEU4 3.9 20.9 1.0 CD B:GLN110 4.2 37.3 1.0 OE1 B:GLN110 4.3 39.6 1.0 N B:GLU6 4.3 21.9 1.0 CG B:GLU6 4.4 26.1 1.0 CA B:VAL5 4.5 22.0 1.0 C3 B:GOL202 4.5 30.6 1.0 N A:GLN110 4.5 19.1 1.0 N B:VAL5 4.6 21.6 1.0 CD B:GLU6 4.7 27.0 1.0 O3 B:GOL202 4.7 28.2 1.0 CB B:LEU4 4.7 18.0 1.0 O1 B:GOL202 4.7 25.4 1.0 OE2 B:GLU6 4.8 25.9 1.0 CA A:GLN110 4.8 21.2 1.0 N B:GLY109 4.8 20.1 1.0 CB B:GLU6 4.8 25.3 1.0 NE2 A:GLN110 4.8 29.9 1.0 O B:GLY109 4.9 22.8 1.0 C B:VAL5 4.9 23.5 1.0 CA B:LEU4 4.9 20.3 1.0 O A:LEU4 5.0 27.0 1.0 O A:HOH302 5.0 32.0 1.0

E.P.Harvey, J.E.Shin, M.A.Skiba, G.R.Nemeth, J.D.Hurley, A.Wellner, A.Y.Shaw, V.G.Miranda, J.K.Min, C.C.Liu, D.S.Marks, A.C.Kruse. An in Silico Method to Assess Antibody Fragment Polyreactivity. Nat Commun V. 13 7554 2022.
ISSN: ESSN 2041-1723
PubMed: 36477674
DOI: 10.1038/S41467-022-35276-4